138 related articles for article (PubMed ID: 2652512)
1. A new triple-drug induction therapy with low dose cyclosporine, mizoribine and prednisolone in renal transplantation.
Kokado Y; Ishibashi M; Jiang H; Takahara S; Sonoda T
Transplant Proc; 1989 Feb; 21(1 Pt 2):1575-8. PubMed ID: 2652512
[No Abstract] [Full Text] [Related]
2. Studies on immunosuppression with low-dose cyclosporine combined with mizoribine in experimental and clinical cadaveric renal allotransplantation.
Osakabe T; Uchida H; Masaki Y; Yokota K; Sato K; Nakayama Y; Ohkubo M; Kumano K; Endo T; Watanabe K
Transplant Proc; 1989 Feb; 21(1 Pt 2):1598-600. PubMed ID: 2652520
[No Abstract] [Full Text] [Related]
3. Advantages of mizoribine over azathioprine in combination therapy with cyclosporine for renal transplantation.
Mita K; Akiyama N; Nagao T; Sugimoto H; Inoue S; Osakabe T; Nakayama Y; Yokota K; Sato K; Uchida H
Transplant Proc; 1990 Aug; 22(4):1679-81. PubMed ID: 2202125
[No Abstract] [Full Text] [Related]
4. Immunosuppression with low-dose cyclosporine combined with bredinin and prednisolone.
Aso K; Uchida H; Sato K; Yokota K; Osakabe T; Nakayama Y; Ohkubo M; Kumano K; Endo T; Koshiba K
Transplant Proc; 1987 Feb; 19(1 Pt 3):1955-8. PubMed ID: 3547900
[No Abstract] [Full Text] [Related]
5. Immunosuppression with low-dose cyclosporine, mizoribine, and steroids in living-related kidney transplantation.
Takeuchi N; Ohshima S; Matsuura O; Ono Y; Katoh N; Yamada S; Fujita T; Kinukawa T; Hirabayashi S; Sahashi M
Transplant Proc; 1994 Aug; 26(4):1907-9. PubMed ID: 8066621
[No Abstract] [Full Text] [Related]
6. Decreased interleukin 2 production and increased LEU 2a-positive suppressor cells in renal transplant patients on triple therapy with mizoribine, cyclosporine A, and prednisolone.
Okubo M; Kaneko Y; Mizukoshi M; Inoue K; Sato N; Kamata K; Chen XM; Uchida H; Endo T
Transplant Proc; 1987 Feb; 19(1 Pt 3):1940-3. PubMed ID: 2950635
[No Abstract] [Full Text] [Related]
7. Synergistically enhanced immunosuppressive effect by combined use of cyclosporine and mizoribine.
Amemiya H; Suzuki S; Watanabe H; Hayashi R; Niiya S
Transplant Proc; 1989 Feb; 21(1 Pt 1):956-8. PubMed ID: 2650298
[No Abstract] [Full Text] [Related]
8. Synergistic effect of cyclosporine and mizoribine on graft survival in canine organ transplantation.
Hayashi R; Suzuki S; Shimatani K; Watanabe H; Kenmochi T; Fukuoka T; Niiya S; Amemiya H
Transplant Proc; 1990 Aug; 22(4):1676-8. PubMed ID: 2389432
[No Abstract] [Full Text] [Related]
9. Perioperative hyperamylasemia in cyclosporine-treated renal transplant recipients: does it have clinical significance?
Ihara H; Ogino T; Hosokawa S; Yabumoto H; Arima M; Ikoma F
Transplant Proc; 1989 Feb; 21(1 Pt 2):2147-50. PubMed ID: 2469231
[No Abstract] [Full Text] [Related]
10. Subpopulations of peripheral blood mononuclear cells are reliable for monitoring infiltrating mononuclear cells.
Takahara S; Sakakibara I; Suzuki S; Amemiya H; Kokado Y; Ishibashi M; Sonoda T
Transplant Proc; 1989 Feb; 21(1 Pt 2):1846-51. PubMed ID: 2652601
[No Abstract] [Full Text] [Related]
11. Immunopharmacologic effects of immunosuppressive agents explored by a new effector monocyte generation assay.
Ishibashi M; Jiang S; Kokado Y; Takahara S; Sonoda T
Transplant Proc; 1989 Feb; 21(1 Pt 2):1854-8. PubMed ID: 2469228
[No Abstract] [Full Text] [Related]
12. A comparison of triple therapy with double therapy (cyclosporine/azathioprine) in low-risk, first cadaveric renal allograft recipients.
Restifo AC; Petrie JJ; Rigby RJ; Hardie IR; Jacob CK; Russ GR; Mathew TH
Transplant Proc; 1989 Feb; 21(1 Pt 2):1604-5. PubMed ID: 2652522
[No Abstract] [Full Text] [Related]
13. Plasma endothelin level following kidney transplantation.
Kumano K; Masui N; Soh S; Mashimo S; Endo T
Transplant Proc; 1994 Aug; 26(4):2114-6. PubMed ID: 8066688
[No Abstract] [Full Text] [Related]
14. Immunosuppressive therapy using CsA, MZ, steroids, and DSG during the early phase after kidney grafting, with later steroid withdrawal.
Suzuki S; Hayashi R; Nakatani T; Amemiya H
Transplant Proc; 1994 Aug; 26(4):2065-6. PubMed ID: 8066671
[No Abstract] [Full Text] [Related]
15. Pancreaticoduodenal allotransplantation with the use of FK 506, cyclosporine, and triple-regimen immunosuppression.
Imai K; Sato K; Takishima T; Nakayama Y; Osakabe T; Yokota K; Yamagishi K; Uchida H; Hiki Y
Transplant Proc; 1990 Aug; 22(4):1655-7. PubMed ID: 1697117
[No Abstract] [Full Text] [Related]
16. Mizoribine as an alternative to azathioprine in triple therapy immunosuppressant regimens in cadaveric renal transplantation: two successive studies.
Lee HA; Slapak M; Raman GV; Mason JC; Digard N; Wise M
Transplant Proc; 1995 Feb; 27(1):1050-1. PubMed ID: 7878799
[No Abstract] [Full Text] [Related]
17. Renal graft histology in patients treated with different doses of cyclosporine.
Wilczek HE; Bohman SO; Groth CG
Transplant Proc; 1989 Feb; 21(1 Pt 2):1672-3. PubMed ID: 2652547
[No Abstract] [Full Text] [Related]
18. Living-related kidney transplantation using low-dose triple immunosuppression.
Rashid HU; Rahman M; Wahab MA; Kibria G; Rahman S; Jinnat S
Transplant Proc; 1994 Aug; 26(4):2089. PubMed ID: 8066680
[No Abstract] [Full Text] [Related]
19. Discontinuation of one drug in triple drug treatment of renal allograft patients: 1-year results.
Isoniemi H; Eklund B; Höckerstedt K; Korsbäck C; Salmela K; von Willebrand E; Häyry P; Ahonen J
Transplant Proc; 1990 Aug; 22(4):1365-6. PubMed ID: 2202111
[No Abstract] [Full Text] [Related]
20. Effect of a novel immunosuppressive agent, deoxyspergualin, on rejection in kidney transplant recipients.
Takahashi K; Ota K; Tanabe K; Oba S; Teraoka S; Toma H; Agishi T; Kawaguchi H; Ito K
Transplant Proc; 1990 Aug; 22(4):1606-12. PubMed ID: 2389420
[No Abstract] [Full Text] [Related]
[Next] [New Search]
